PT141, also known as Bremelanotide, is a unique peptide that has gained traction in the medical and research communities due to its potential to improve sexual dysfunction symptoms in both men and women. It was FDA-approved in 2019 as a treatment for generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, and the peptide has since been marketed under the brand name Vyleesi.
Unlike Viagra and other ED medications that work by opening blood flow to the penis, PT141 binds to the melanocortin receptors in the brain and works directly on your nervous system to increase sexual arousal. The peptide is normally administered by subcutaneous injection, usually in the areas of your body with fat deposits. The peptide can also be delivered by orally, nasal sprays, or creams, but those methods have not been proven to be effective.
Peptide 141 is an extremely safe medication, but it may not be suitable for all people. Before using it, you should speak to your doctor about your current health status and any other medications or supplements you are taking. The peptide can interact with some drugs, so it is important to check the list of drug interactions on the packaging or ask your doctor about any potential side effects.
In addition, you should always buy peptides from a reliable seller that publishes third-party laboratory results to confirm the identity, purity, and quality of their products. Avoid buying peptides from online vendors that do not provide these details, as they may be diluted or contaminated.